SLXN (Silexion Therapeutics) Pretax Margin % : % (As of Dec. 2024)

View and export this data going back to 2024. Start your Free Trial

What is Silexion Therapeutics Pretax Margin %?

Pre-Tax margin is calculated as Pre-Tax Income divided by its Revenue. Silexion Therapeutics's Pre-Tax Income for the three months ended in Dec. 2024 was $-1.75 Mil. Silexion Therapeutics's Revenue for the three months ended in Dec. 2024 was $0.00 Mil. Therefore, Silexion Therapeutics's pretax margin for the quarter that ended in Dec. 2024 was %.

The historical rank and industry rank for Silexion Therapeutics's Pretax Margin % or its related term are showing as below:

SLXN's Pretax Margin % is not ranked ^*
in the Biotechnology industry.
Industry Median: -134.73
* Ranked among companies with meaningful Pretax Margin % only.

Silexion Therapeutics Pretax Margin % Historical Data

The historical data trend for Silexion Therapeutics's Pretax Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Silexion Therapeutics Pretax Margin % Chart

Silexion Therapeutics Annual Data

Trend

Dec22

Dec23

Dec24

Pretax Margin %

Silexion Therapeutics Quarterly Data
	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Pretax Margin %	Get a 7-Day Free Trial				-	-	-	-	-

Competitive Comparison of Silexion Therapeutics's Pretax Margin %

For the Biotechnology subindustry, Silexion Therapeutics's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Silexion Therapeutics's Pretax Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Silexion Therapeutics's Pretax Margin % distribution charts can be found below:

* The bar in red indicates where Silexion Therapeutics's Pretax Margin % falls into.

Save Embed

;

Save Embed

;

Silexion Therapeutics Pretax Margin % Calculation

Pretax margin - also known as pretax profit margin is the ratio of Pretax Income divided by net sales or Revenue, usually presented in percent.

Silexion Therapeutics's Pretax Margin for the fiscal year that ended in Dec. 2024 is calculated as

Pretax Margin	=	Pre-Tax Income (A: Dec. 2024 )	/	Revenue (A: Dec. 2024 )
	=	-16.509	/	0
	=	%

Silexion Therapeutics's Pretax Margin for the quarter that ended in Dec. 2024 is calculated as

Pretax Margin	=	Pre-Tax Income (Q: Dec. 2024 )	/	Revenue (Q: Dec. 2024 )
	=	-1.746	/	0
	=	%

Silexion Therapeutics (NAS:SLXN) Pretax Margin % Explanation

The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.

The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.

It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.

The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.

Silexion Therapeutics Pretax Margin % Related Terms

Thank you for viewing the detailed overview of Silexion Therapeutics's Pretax Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Silexion Therapeutics Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Silexion Therapeutics Corp (NAS:SLXN) » Definitions » Pretax Margin %

Comparable Companies

Traded in Other Exchanges

N/A

Address

2 Ha mayan Street, Modi in-Maccabim-Reut, ISR, 7177871

Website

https://www.silexion.com

Silexion Therapeutics Corp is a developmental-stage company dedicated to the development of treatments for pancreatic cancer. The company is focused on enhancing its first-generation product (LODERTM ) to develop a newly formulated product to improve the clinical efficacy against pancreatic cancer.